Answers are grounded in this paper and cite their sources.
Paracetamol (PCT), a widely used drug, is increasingly present in environmental and pharmaceutical samples, raising the need for monitoring and control. Electrochemical sensors (ES) and electrochemical biosensors (EBS) have proven to be promising analytical methods for PCT detection. This review aims to provide a comprehensive comparison of ES and EBS for PCT detection, highlighting advances in electrode modification strategies, signal amplification approaches and biological recognition elements. The reported limits of detection range from the picomolar level (≈10 pM in immunosensors) to the micromolar range, varying with material design and recognition element. Carbon-based and metal/metal oxide materials enhance sensitivity through improved electron transfer and catalytic activity. Enzymatic and antibody-based sensors provide higher selectivity. The drawbacks of enzymatic and non-enzymatic biosensors are low long-term stability, enzyme degradation, lack of interference testing in different sample matrices and lack of standardized protocols. Antibody- and DNA-based electrochemical platforms for PCT are under-analysed fields compared to nanomaterial-driven approaches. This review also identifies current challenges, the need for standardised protocols and key drawbacks of ES and EBS systems. Future perspectives for the development of hybrid, portable, miniaturized, and real-time monitoring systems are further outlined.
No takes yet. Share an insight, caveat, or question.
Nagendran et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: